Both Resting and Activated B Lymphocytes Expressing Engineered Peptide-Ig Molecules Serve as Highly Efficient Tolerogenic Vehicles in Immunocompetent Adult Recipients

Journal of Immunology

Volumn 158, Issue 5, 1997, Pages 2174-2182

  Zambidis, Elias T ^a,b   Barth, Richard K ^b   Scott, David W ^a,b  

^a HOLLAND LABORATORY   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HYBRID PROTEIN; IMMUNOGLOBULIN G; PEPTIDE FRAGMENT;

AGE; AMINO ACID SEQUENCE; ANIMAL; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW; C57BL MOUSE; CELLULAR IMMUNITY; CYTOLOGY; FEMALE; GENETICS; IMMUNIZATION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTERPHASE; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MALE; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN ENGINEERING; RADIATION CHIMERA; RADIATION EXPOSURE; TRANSGENIC MOUSE; TRANSPLANTATION;

AGE FACTORS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-PRESENTING CELLS; B-LYMPHOCYTES; BONE MARROW; EPITOPES; FEMALE; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNOGLOBULIN G; INTERPHASE; LYMPHOCYTE ACTIVATION; LYMPHOID TISSUE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PROTEIN ENGINEERING; RADIATION CHIMERA; RECOMBINANT FUSION PROTEINS;

EID: 0031093505     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Bretscher, P. A., and M. Cohn. 1970. A theory of self-nonself discrimination. Science 169:1042.
2. Wu, Y., J. Xu, S. Shinde, I. Grewal, T. Henderson, R. A. Flavell, and Y. Liu. 1995. Rapid induction of a novel costimulatory activity on B cells by CD40 ligand. Curr. Biol. 5:1303.
3. Mueller, D. L., M. K. Jenkins, and R. H. Schwartz. 1989. Clonal expansion vs. functional clonal inactivation: a costimulatory signaling pathway determines the outcome of the T cell antigen receptor co-occupancy. Annu. Rev. Immunol. 7:445.
4. Parker, D. C. 1993. T-cell dependent B-cell activation. Annu. Rev. Immunol. 11:331.
5. Ron, Y., B. R. De, J. Gordon, M. Feldman, and S. Segal. 1981. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. Eur. J. Immunol. 11:964.
6. Janeway, C. J., Y. Ron, and M. E. Katz. 1987. The B cell is the initiating antigen-presenting cell in peripheral lymph nodes. J. Immunol. 138:1051.
7. + T cells to protein antigens in vivo. J. Immunol. 155:3734.
8. Morris, S. C., A. Lees, and F. D. Finkelman. 1994. In vivo activation of naive T cells by antigen-presenting B cells. J. Immunol. 152:3777.
9. Sunshine, G. H., B. L. Jimmo, C. Ianelli, and L. Jarvis. 1991. Strong priming of T cells adoptively transferred into SCID mice. J. Exp. Med. 174:1653.
10. Ronchese, F., and B. Hausman. 1993. B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes. J. Exp. Med. 177: 679.
11. Epstein, M. M., F. DiRosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice J. Exp. Med. 182:915.
12. Eynon, E. E., and D. C. Parker. 1991. Do small B cells induce tolerance? Transplant. Proc. 23:729.
13. Eynon, E. E., and D. C. Parker. 1992. Small B cells as antigen-presenting cells in the induction of tolerance to soluble protein antigens. J. Exp. Med. 175:131.
14. Fuchs, E. J., and P. Matzinger. 1992. B cells turn off virgin but not memory T cells. Science 258:1156.
15. Buhlmann, J. E., T. M. Foy, A. Aruffo, K. M. Cerassi, J. A. Ledbetter, W. R. Green, J. C. Xu, L. D. Shultz, D. Roopesian, R. A. Flavell, L. Fast, R. J. Noelle, and F. H. Durie. 1995. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 2:645.
16. Gilbert, K. M., and W. O. Weigle. 1994. Tolerogenicity of resting and activated B cells. J. Exp. Med. 179:249.
17. + T cells. J. Exp. Med. 179:1539.
18. Cassell, D. J., and R. H. Schwartz. 1994. A quantitative analysis of antigen-presenting cell function: activated B cells stimulate naive CD4 T cells but are inferior to dendritic cells in providing costimulation. J. Exp. Med. 180:1829.
19. Lenschow, D. J., A. I. Sperling, M. P. Cooke, G. Freeman, L. Rhee, D. C. Decker, G. Gray, L. M. Nadler, C. C. Goodnow, and J. A. Bluestone. 1994. Differential up-regulation of the B7-1 and B7-2 costimulating molecules after Ig receptor engagement by antigen. J. Immunol. 153:1990.
20. Guillet, J. G., M.-Z. Lai, T. Briner, J. A. Smith, and M. Gefter. 1986. Interaction of peptide antigens and class II major histocompatibility complex antigens. Nature 324:260.
21. Lai, M.-Z., D. Ross, J. G. Guillet, T. Briner, M. Gefter, and J. A. Smith. 1987. T lymphocyte response to bacteriophage λ repressor cI protein. J. Immunol. 139: 3973.
22. Roy, S., M. T. Scherer, T. Briner, J. A. Smith, and M. Gefter. 1989. Murine MHC polymorphism and T cell specificities. Science 244:575.
23. Scherer, M. T., F. R. Chan, J. A. Smith, D. L. Perkins, and M. Gefter. 1989. Control of cellular and humoral immune responses by peptides containing T-cell epitopes. Cold Spring Harbor Symp. Quant. Biol. LIV:497.
24. Soloway, P., S. Fish, H. Passmore, M. Gefter, R. Coffee, and T. Manser. 1991. Regulation of the immune response to peptide antigens: differential induction of immediate-type hypersensitivity and T-cell proliferation due to changes in either peptide structure or major histocompatibility complex haplotype. J. Exp. Med. 174:847.
25. Zambidis, E. T., and D. W. Scott. 1996. Epitope-specific tolerance induction with an engineered immunoglobulin. Proc. Natl. Acad. Sci. USA 93:5019.
26. Ballard, D. W., and A. Bothwell. 1986. Mutational analysis of the immunoglobulin heavy chain promoter region. Proc. Natl. Acad. Sci. USA 83:9626.
27. Hogan, B., F. Costantini, and E. Lacy. 1986. Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Plainview, NY, pp. 81-141.
28. Mathis, D. J., C. Bemoist, V. E. Williams, M. Kanter, and H. O. McDevitt. 1983. Several mechanisms can account for defective Ea gene expression in different mouse haplotypes. Proc. Natl. Acad. Sci. USA 80:273.
29. Grosschedl, R., D. Weaver, D. Baltimore, and F. Costantini. 1984. Introduction of a μ immunoglobulin gene into the mouse germ line: specific expression in lymphoid cells and synthesis of functional antibody. Cell 38:647.
30. Storb, U. 1987. Transgenic mice with immunoglobulin genes. Annu. Rev. Immunol. 5:151.
31. Weaver, D., F. Costantini, T. Imanishi-Kari, and D. Baltimore. 1985. A transgenic immunoglobulin mu prevents rearrangement of endogenous genes. Cell 42:117.
32. 1 heavy-chain immunoglobulin gene in transgenic mice. Proc. Natl. Acad. Sci. USA 83:2152.
33. Tsao, B. P., K. Ohnishi, H. Cheroutve, B. Mitchell, M. Teitell, P. Mixter, M. Kronenberg, and B. H. Hahn. 1992. Failed self-tolerance and autoimmunity in IgG anti-DNA transgenic mice. J. Immunol. 149:350.
34. Radic, M. Z., S. M. Ibrahim, J. Rauch, S. A. Compar, and M. Weigert. 1995. Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease. J. Immunol. 155:3213.
35. Ashwell, J. D., A. L. Defranco, W. E. Paul, and R. H. Schwartz. 1984. Antigen presentation by resting B cells. J. Exp. Med. 159:881.
36. Miller, S. D., R. P. Wetzig, and H. N. Claman. 1979. The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J. Exp. Med. 149:758.
37. Jenkins, M. K., and R. H. Schwartz. 1987. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165:302.
38. Hu-Li, J., J. Ohara, C. Watson, W. Tsang, and W. E. Paul. 1989. Derivation of a T-cell line that is highly responsive to IL-4 and IL-2 (CT.4R) and of an IL-2 hyporesponsive mutant of that line (CT.4S). J. Immunol. 142:800.
39. Goodnow, C. C. 1992. Transgenic mice and analysis of B cell tolerance. Annu. Rev. Immunol. 10:489.
40. Miller, J. F. A. P., and G. Morahan. 1992. Peripheral T cell tolerance. Annu. Rev. Immunol. 10:51.
41. Ildstad, S. T., and D. H. Sachs. 1984. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 307:168.
42. Cobbold, S. P. A. Jayasuriya, A. Nash, T. D. Prospero, and H. Waldmann. 1984. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312:548.
43. Roberts, J. L., S. O. Sharrow, and A. Singer. 1990. Clonal deletion and clonal anergy in the thymus induced by cellular elements with different radiation sensitivities. J. Exp. Med. 171:935.
44. Oehen, S. V., P. A. Ohashi, K. Bürki, H. Hengartuer, R. M. Zinkernagel, and P. Aichele. 1994. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell. Immunol. 158:342.
45. Nemazee, D., and K. Bürki. 1989. Clonal deletion of autoreactive B lymphocytes in bone marrow chimeras. Proc. Natl. Acad. Sci. USA 86:8039.
46. Gosselin, E. J., H.-P. Tony, and D. C. Parker. 1988. Characterization of antigen processing and presentation by resting B lymphocytes. J. Immunol. 140:1408.
47. Jenkins, M. K., E. Burrell, and J. D. Ashwell. 1990. Antigen presentation by resting B cells: effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy. J. Immunol. 144:1585.
48. Hathcock, K. S., G. Laszlo, C. Pucillo, P. Linsley, and R. J. Hodes. 1994. Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J. Exp. Med. 180:631.
49. Stack, R. M., D. J. Lenschow, G. S. Gray, J. A. Bluestone, and F. W. Fitch. 1994. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J. Immunol. 152:5723.
50. Ranheim, E. A., and T. J. Kipps. 1993. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177:925.
51. Chiller, J. M., G. S. Habicht, and W. O. Weigle. 1970. Cellular sites of immunologic unresponsiveness. Proc. Natl. Acad. Sci. USA 65:551.
52. Parks, D. E., and W. O. Weigle. 1980. Maintenance of immunologic unresponsiveness to human γ-globulin: evidence for irreversible inactivation in B lymphocytes. J. Immunol. 124:1230.
53. Tighe, H., P. Heaphy, S. Baird, W. O. Weigle, and D. A. Carson. 1995. Human immunoglobulin (IgG) induced deletion of IgM rheumatoid factor B cells in transgenic mice. J. Exp. Med. 181:599.
54. Adelstein, S., H. Pritchard-Briscoe, T. A. Anderson, J. Crosbie, G. Gammon, R. H. Loblay, A. Basten, and C. C. Goodnow. 1991. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self Ag. Nature 251:1223.
55. Eynon, E. E., and D. C. Parker. 1993. Parameters of tolerance induction by antigen targeted to B lymphocytes. J. Immunol. 151:2958.
56. Parker, D. C., D. L. Greiner, N. E. Phillips, M. C. Appel, A. W. Steele, F. H. Durie, R. J. Noelle, J. P. Mordes, and A. A. Rossini. 1995. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc. Natl. Acad. Sci. USA 92:9560.
57. Asherson, G. L., and S. H. Stone. 1965. Selective and specific inhibition of 24 hour skin reactions in the guinea-pig. I. Immune deviation: description of the phenomenon and the effect of splenectomy. Immunology 9:206.
58. Bikoff, E., and B. K. Birshtein. 1986. T cell clones specific for IgG2a of the a allotype: direct evidence for presentation of endogenous Ag. J. Immunol. 137:28.
59. Bikoff, E. K., and L. A. Eckhardt. 1989. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells. Eur. J. Immunol. 19:1903.
60. Yurin, V. L., A. Y. Rudensky, S. M. Mazel, and J. M. Blechman. 1989. Immunoglobulin-specific T-B cell interaction. II. T cell clones recognize the processed form of B cells' own surface immunoglobulin in the context of the major histocompatibility complex class II molecule. Eur. J. Immunol. 19:1685.
61. Weiss, S., and B. Bogen. 1989. B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc. Natl. Acad. Sci. USA 86:282.
62. + T cell activation and tolerance induction in B cell knockout mice. J. Exp. Med. 183:1339.
63. Zambidis, E. Z., A Kurup, and D. W. Scott. 1997. Genetically-transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Molecutar Medicine. In press.
64. Yuschenkoff, V., M. Sethna, G. Freeman, and D. C. Parker. 1996. Coexpression of B7-1 and antigen blocks tolerance induction to antigen presented by resting B cells. J. Immunol. 157:1987.
65. Crispe, I. N. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1:347.
66. Critchfield, J. M., M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman, and M. J. Lenardo. 1994. T cell deletion in high antigen dose therapy of autoimmune encephalitis. Science 263:1139.
67. Singer, G. G., and A. K. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365.
68. Pulendran, B., G. Kannourakis, S. Nouri, K. G. C. Smith, and G. J. V. Nossal. 1995. Soluble antigen can cause enhanced apoptosis of germinal-center B cells. Nature 375:331.
69. Shokat, K. M., and C. C. Goodnow. 1995. Antigen-induced B-cell death and elimination during germinal-center immune responses. Nature 375:334.
70. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.